Results 131 to 140 of about 22,974 (229)

Authors' reply to the letter to the editor regarding "Low-dose naltrexone for fibromyalgia: a re-analysis suggests lower efficacy than previously reported". [PDF]

Korean J Pain
Hariyanto TI, Vatvani AD, Patel P, Yanto TA.   +3 more
europepmc   +1 more source

Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population

, 2017
Jake R. Morgan, Bruce R. Schackman, Jared A. Leff, Benjamin P. Linas, Alexander Y. Walley   +4 more
openalex   +2 more sources

Methodological considerations for interpreting ketamine-naltrexone trials in depression. [PDF]

Int J Neuropsychopharmacol
Bandeira ID, Jelen LA, Tucciarone JM, Heifets BD, Rodriguez CI, Schatzberg AF.   +5 more
europepmc   +1 more source

Regarding naltrexone for probationers and parolees [PDF]

, 2007
Sharon Stancliff
openalex   +1 more source

Intraoperative pain management for patients undergoing medication-assisted rehabilitation: a scoping review. [PDF]

BMC Anesthesiol
Henriksen M, Ellingsen S, Kaldheim HKA.
europepmc   +1 more source

Preparation of Oral Naltrexone Solution [PDF]

, 1990
T. K. Abboud
openalex   +1 more source

Predictors of naltrexone prescribing for alcohol use disorder from the emergency department. [PDF]

Alcohol Clin Exp Res (Hoboken)
Lebin JA, Hensen C, Lun Z, Kwan BM, Goldberg EM, Burnham EL, Hoppe JA.   +6 more
europepmc   +1 more source

Identifying Extended-Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data. [PDF]

Pharmacoepidemiol Drug Saf
Ross RK, Butler AM, Seamans MJ, Williams AR, Samples H, Rudolph KE.   +5 more
europepmc   +1 more source

Baseline Moderators of Response to Naltrexone and Bupropion in the Treatment of Methamphetamine Use Disorder: An ADAPT-2 Study

Thomas Carmody, Taryn L. Mayes, Manish K. Jha, Steven Shoptaw, Madhukar H. Trivedi   +4 more
openalex   +2 more sources

Medication Adherence Monitoring Using Smartphone Video Dosing in an Open-label Pilot Study of Monthly Naltrexone Plus Once-daily Bupropion for Methamphetamine Use Disorder: Feasibility and Acceptability

, 2019
Robrina Walker, Maureen Hillhouse, Brian Perrochet, Steven Sparenborg, Larissa J. Mooney, Walter Ling   +5 more
openalex   +2 more sources